(Q40682111)

22 September 2017

title

Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures (English)

1 reference

22 September 2017

L M Goodnough

1

1 reference

22 September 2017

J E Grishaber

2

1 reference

22 September 2017

J D Birkmeyer

3

1 reference

22 September 2017

T G Monk

4

1 reference

22 September 2017

W J Catalona

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

44

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

226-231

1 reference

Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Effect of Temporary Occlusion of Hypogastric Arteries on Blood Loss During Radical Retropubic Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Relation of circulating red cell volume to body density and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Identifying elective orthopedic surgical patients transfused with amounts of blood in excess of need: the transfusion trigger revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Blood transfusion costs: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The risk of transfusion-transmitted infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The safety of preoperative autologous blood donation in the nonhospital setting

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Transfusion and host defenses against cancer recurrence and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Blood transfusion and postoperative infection in orthopedic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The impact of preoperative autologous blood donation on orthopaedic surgical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Risks, options, and informed consent for blood transfusion in elective surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Utilization and efficacy of autologous blood predeposit in radical prostatectomy with lymphadenectomy: implications for blood conservation and physician education programs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Efficacy of preoperative donation of blood for autologous use in radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Impact of autologous blood transfusions on patients undergoing radical prostatectomy using hypotensive anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Autologous blood donation in nonorthopaedic surgical procedures as a blood conservation strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Screening for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Cost-effectiveness analysis of transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Cost-effectiveness of interventions to prevent or treat coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Con

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

Mathematical and computer modeling of acute normovolemic hemodilution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980136-3

7 January 2021

10.1016/S0090-4295(94)80136-3

Identifiers

DOI

1 reference

release_6f7k3yf3yrgslg4cpltb2l4tc4

22 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6f7k3yf3yrgslg4cpltb2l4tc4

24 November 2022

mapped directly with Wikidata item

1 reference